Biologic drugs, made mainly from antibodies, have transformed the approach to treating chronic inflammatory diseases such as asthma and rheumatoid arthritis. We explore their mechanisms and potential.

The DHODH inhibitor market is poised for steady growth, fueled by the rising burden of autoimmune and inflammatory diseases, along with incre ...

You just finished a satisfying summer hike or wrapped up a weekend of yard work when you spot a tick clinging to your clothes ...